UMMY18121 / Amgen Deno Smol Lipe IIT / Brea Lipe
Research Question:
Is denosumab, delivered as an injection under the skin, safe and well-tolerated in
people with smoldering multiple myeloma? And can denosumab reduce the risk of getting
multiple myeloma?
Basic Study Information
Purpose:
This study will assess the safety and tolerability of denosumab in smoldering multiple
myeloma subjects as well to see if denosumab can reduce subjects' risk of getting
multiple myeloma.
Location: University of Rochester Medical Center
Study Reference #: UMMY18121
Lead Researcher (Principal Investigator)
Lead Researcher:
Brea Lipe
Study Contact Information
Study Coordinator: Lauren Mitchell
Email: lauren_mitchell@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search